TY - JOUR
T1 - Portal vein thrombosis risk factors in liver transplant candidates
AU - Cagatay, Ak
AU - Adali, Gupse
AU - Sayar, Suleyman
AU - Agackiran, Abdulbaki
AU - Kulali, Fatma
AU - Kahraman, Resul
AU - Ozturk, Oguzhan
AU - Ozdil, Kamil
AU - Forum, Hepatology
N1 - Publisher Copyright:
© 2022, Kare Publishing. All rights reserved.
PY - 2022/9
Y1 - 2022/9
N2 - Background and Aim: Portal vein thrombosis (PVT) is particularly de-tected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates. Materials and Methods: Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT. Results: Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocy-topenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02–11.6, p=0.046) significantly increased the risk of PVT. Conclusion: The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagu-lation in these patients.
AB - Background and Aim: Portal vein thrombosis (PVT) is particularly de-tected in advanced liver cirrhosis patients. We aimed to analyze the risk factors for PVT in liver transplant candidates. Materials and Methods: Dataset for consecutive 165 cirrhotic patients who were evaluated for liver transplantation (LT) were retrospectively analyzed. We sorted patients into two groups: patients with PVT and patients without PVT. Included variables were age, sex, etiology of liver disease, body mass index, MELD-Na score, Child-Pugh score, clinical variables reflecting portal hypertension, and hepatocellular carcinoma. Univariate and multivariate logistic regression analyses were used to identify risk factors of PVT. Results: Of 165 LT candidates, 46 had PVT (27.9%). Ascites, thrombocy-topenia, history of variceal bleeding, and band ligation were risk factors for PVT in univariate analysis. In multivariate analysis, only a history of variceal bleeding (OR 3.45, 95% CI 1.02–11.6, p=0.046) significantly increased the risk of PVT. Conclusion: The previous history of variceal bleeding predicts PVT development in cirrhosis, suggesting that the severity of portal hypertension is a major predictive factor for PVT in patients with cirrhosis. Future prospective studies are needed to risk stratifying cirrhosis patients prior to LT for future PVT development and to define the prophylactic role of anticoagu-lation in these patients.
KW - Cirrhosis
KW - PVT Risk Index Score
KW - liver transplant
KW - portal vein thrombosis
UR - http://www.scopus.com/inward/record.url?scp=85146717656&partnerID=8YFLogxK
U2 - 10.14744/hf.2022.2022.0005
DO - 10.14744/hf.2022.2022.0005
M3 - Article
AN - SCOPUS:85146717656
SN - 2757-7392
VL - 3
SP - 88
EP - 92
JO - Hepatology Forum
JF - Hepatology Forum
IS - 3
ER -